Prostate Cancer Screening Clinical Trial
Official title:
MRI Screening in Men at High Risk of Developing Prostate Cancer
The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.
In this study the study team hypothesizes MR images will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer. Subjects will receive gadolinium (intravenous contrast agent) as part of their research MRI exam. While the deposition of gadolinium (Gd) has been demonstrated in numerous studies, the clinical consequences of Gd deposition are unknown. Gd enhanced MRI scans provide crucial medical information regarding prostate and prostate cancer imaging and contrast-enhanced images are a component of all guidelines and the PIRADS scoring system. The study team will compare baseline prostate MR images of men at high risk of developing prostate cancer to those without an identifiable predisposition and evaluate the role of a GRS in screening men with at elevated risk of being diagnosed with prostate cancer. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04601272 -
Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions
|
||
| Completed |
NCT04063566 -
ReIMAGINE Prostate Cancer Screening
|
N/A | |
| Completed |
NCT01516801 -
A Pragmatic Trial of the Effect of a Mailed Patient Flyer About Prostate Specific Antigen (PSA) Testing Prior to an Annual Exam
|
N/A | |
| Active, not recruiting |
NCT03633214 -
Evaluation of An Online Intervention In Improving General Practitioners' Practice In Prostate Cancer Screening
|
N/A |